UFPT UFP Technologies, Inc.
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.…
Industry Peers
Medical DevicesKey Statistics
About UFP Technologies (NASDAQ: UFPT)
›
UFP Technologies (NASDAQ: UFPT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 4,846 employees.
The shares were at 298.93 USD on 19 November 2026, up 27.5% over 52 weeks. Its 52-week range is 173.86 USD to 342.11 USD: the price is 12.6% below the high and 71.9% above the low.
At a market capitalisation of 2.32B USD, it trades at 30.5 times trailing earnings and 24.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 19% for UFPT.
UFP Technologies reports return on equity of 16.1%, an operating margin of 15.4% and revenue up 11.6% year over year.
Its debt exceeds its cash by 95.91M USD, a debt-to-equity ratio of 0.36. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 357.50 USD is 19.6% above the current price. The next earnings report is expected on 23 February 2027.